These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33849119)

  • 21. Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers.
    Onozato ML; Tojo A; Leiper J; Fujita T; Palm F; Wilcox CS
    Diabetes; 2008 Jan; 57(1):172-80. PubMed ID: 17909098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.
    Kami Reddy KR; Dasari C; Vandavasi S; Natani S; Supriya B; Jadav SS; Sai Ram N; Kumar JM; Ummanni R
    ACS Comb Sci; 2019 Apr; 21(4):241-256. PubMed ID: 30673277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway.
    Wang Y; Niu M; Yin S; Zhang F; Shi R
    Pharmacol Rep; 2018 Oct; 70(5):917-929. PubMed ID: 30099298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible role for the thioredoxin system in the protective effects of probucol in the pancreatic islets of diabetic rats.
    Liu JH; Liu DF; Wang NN; Lin HL; Mei X
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):528-33. PubMed ID: 21615774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA DANCR deficiency promotes high glucose-induced endothelial to mesenchymal transition in cardiac microvascular cells via the FoxO1/DDAH1/ADMA signaling pathway.
    Wu M; Li T; Li G; Niu B; Wu T; Yan L; Wang S; He S; Huang C; Tong W; Li N; Jiang J
    Eur J Pharmacol; 2023 Jul; 950():175732. PubMed ID: 37116560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymmetric Dimethylarginine Enables Depolarizing Spikes and Vasospasm in Mesenteric and Coronary Resistance Arteries.
    Ng YYH; Dora KA; Lemmey HAL; Lin J; Alden J; Wallis L; Donovan L; Shorthose O; Leiper FC; Leiper J; Garland CJ
    Hypertension; 2024 Apr; 81(4):764-775. PubMed ID: 38226470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
    Abhary S; Burdon KP; Kuot A; Javadiyan S; Whiting MJ; Kasmeridis N; Petrovsky N; Craig JE
    PLoS One; 2010 Mar; 5(3):e9462. PubMed ID: 20209122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of increased endogenous asymmetric dimethylarginine in the hepatic endoplasmic reticulum stress of type 2 diabetic rats.
    Leng YP; Qiu N; Fang WJ; Zhang M; He ZM; Xiong Y
    PLoS One; 2014; 9(2):e97125. PubMed ID: 24918756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt.
    Zhang P; Hu X; Xu X; Chen Y; Bache RJ
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):890-7. PubMed ID: 21212404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
    Xu X; Zhang P; Kwak D; Fassett J; Yue W; Atzler D; Hu X; Liu X; Wang H; Lu Z; Guo H; Schwedhelm E; Böger RH; Chen P; Chen Y
    Basic Res Cardiol; 2017 Aug; 112(5):55. PubMed ID: 28819685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of asymmetric dimethylarginine (ADMA) on heart failure development.
    Liu X; Hou L; Xu D; Chen A; Yang L; Zhuang Y; Xu Y; Fassett JT; Chen Y
    Nitric Oxide; 2016 Apr; 54():73-81. PubMed ID: 26923818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
    Hu X; Atzler D; Xu X; Zhang P; Guo H; Lu Z; Fassett J; Schwedhelm E; Böger RH; Bache RJ; Chen Y
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlations of DDAH1 transcript variants with human endothelial asymmetric dimethylarginine metabolizing activity.
    Sun T; Zhou JP; Kuang DB; Li MP; Xiong Y; Tang J; Xia J; Bai YP; Yang GP; Li YJ; Chen XP
    Am J Hypertens; 2013 Dec; 26(12):1437-44. PubMed ID: 23864585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the arginine methylation of organ proteins during the development of diabetes mellitus.
    Lee JH; Park GH; Lee YK; Park JH
    Diabetes Res Clin Pract; 2011 Oct; 94(1):111-8. PubMed ID: 21855157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activities of asymmetric dimethylarginine-related enzymes in white adipose tissue are associated with circulating lipid biomarkers.
    Iwasaki H
    Diabetol Metab Syndr; 2012 Apr; 4(1):17. PubMed ID: 22546019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dimethylarginine dimethylaminohydrolase 1 regulates nerve growth factor-promoted differentiation of PC12 cells in a nitric oxide-dependent but asymmetric dimethylargenine-independent manner.
    Wang S; Hu CP; Yuan Q; Zhang WF; Zhou Z; Nie SD; Jiang JL; Li YJ
    J Neurosci Res; 2012 Jun; 90(6):1209-17. PubMed ID: 22488726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats.
    Minakuchi H; Wakino S; Hosoya K; Sueyasu K; Hasegawa K; Shinozuka K; Yoshifuji A; Futatsugi K; Komatsu M; Kanda T; Tokuyama H; Hayashi K; Itoh H
    Nephrol Dial Transplant; 2016 Mar; 31(3):413-23. PubMed ID: 26516203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dimethylarginine dimethylaminohydrolase 1 protects PM
    Gao J; Lei T; Wang H; Luo K; Wang Y; Cui B; Yu Z; Hu X; Zhang F; Chen Y; Ding W; Lu Z
    Part Fibre Toxicol; 2022 Oct; 19(1):64. PubMed ID: 36242005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
    Lin KY; Ito A; Asagami T; Tsao PS; Adimoolam S; Kimoto M; Tsuji H; Reaven GM; Cooke JP
    Circulation; 2002 Aug; 106(8):987-92. PubMed ID: 12186805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced asymmetric dimethylarginine accumulation through inhibition of the type I protein arginine methyltransferases promotes renal fibrosis in obstructed kidneys.
    Wu M; Lin P; Li L; Chen D; Yang X; Xu L; Zhou B; Wang C; Zhang Y; Luo C; Ye C
    FASEB J; 2019 Jun; 33(6):6948-6956. PubMed ID: 30840839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.